Translator Disclaimer
Presentation
6 March 2020 Transperineal laser ablation treatment of benign prostatic obstruction: preliminary results of a pilot study (Conference Presentation)
Author Affiliations +
Abstract
Transperineal laser ablation (TPLA) is a novel minimal invasive treatment of benign prostatic obstruction. TPLA can be performed in an outpatient day-care setting under local anesthesia with optional conscious sedation. The mechanism is bases on thermoablation resulting in coagulative necrosis, which is induced by the laser light of 1064nm. Laser light is delivered in the prostate trough transperineal placed needles. This study aims to treat 20 men by TPLA to evaluate safety and feasibility, and voiding outcomes. TPLA has the potential to become an alternative for standard treatments with urethral approach that require general or spinal anesthesia and hospital admittance.
Conference Presentation
© (2020) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Rob van Kollenburg, Luigi van Riel, Jorg Oddens, Theo de Reijke, Harrie Beerlage, and Martijn de Bruin "Transperineal laser ablation treatment of benign prostatic obstruction: preliminary results of a pilot study (Conference Presentation)", Proc. SPIE 11212, Therapeutics and Diagnostics in Urology 2020, 1121203 (6 March 2020); https://doi.org/10.1117/12.2545579
PROCEEDINGS
PRESENTATION


SHARE
Advertisement
Advertisement
Back to Top